Brief: Jiangsu Recbio Technology Says Component Recombinant Covid-19 Vaccine Got EUA In Mongolia
20/03/2023 12:18
March 20 (Reuters) - Jiangsu Recbio Technology Co Ltd
2179.HK :
* COMPONENT RECOMBINANT COVID-19 VACCINE RECOV- GRANTED WITH
EMERGENCY USE AUTHORIZATION IN MONGOLIA
Source text for Eikon: ID:
Further company coverage: 2179.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jiangsu Recbio Technology
See all newsBrief: Jiangsu Recbio Technology To Re-Plan Timetable For HPV Vaccine Marketing Application
Brief: Jiangsu Recbio Technology Says New Drug Application For REC610 Shingles Vaccine Accepted By NMPA
Brief: Jiangsu Recbio Technology Says Liu Yong Resigned As Chair
Brief: Jiangsu Recbio Technology Says Li Bu Resigned As Executive Director
Brief: Jiangsu Recbio Technology Says Acceptance By CSRC Of Application Materials For Issuance Of Shares